Loree Larratt

5.0k citations
80 papers · 3.1k indexed · 1 hit paper · h-index 28

Loree Larratt

77 papers receiving 3.0k citations

Hit Papers

Ibrutinib plus obinutuzumab versus chlorambucil plus obin...3802018202620202023100200300

Peers

Loree Larratt
Comparison fields: 5 of 95
  • Genetics 1.3k
  • Hematology 1.2k
  • Pathology and Forensic Medicine 1.0k
  • Immunology 831
  • Transplantation 87
Replace Amy E. DeZern with:
Amy E. DeZern United States
Felicetto Ferrara Italy
H M Lokhorst Netherlands
Anders Österborg Sweden
Tibor Kovacsovics United States
Donna M. Weber United States
Jeffrey A. Zonder United States
Massimo Gentile Italy
RJ Jones United States
Luca Maurillo Italy
Loree Larratt relative to Amy E. DeZern United States Amy E. DeZern's profile →
Citations per field
00.5×5.7×
Amy E. DeZern · 1×
Citations per year

Countries citing papers authored by Loree Larratt

Since Specialization
Citations

This map shows the geographic impact of Loree Larratt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loree Larratt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loree Larratt more than expected).

Fields of papers citing papers by Loree Larratt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Loree Larratt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loree Larratt. The network helps show where Loree Larratt may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Loree Larratt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Loree Larratt Line = papers co-authored together Loree Larratt links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202279
2 20219
3 20219
4 202134
5 202094
6 202014
7
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trialbreakdown →
2018380
8 201619
9 201516
10 201444
11 201327
12 200949
13 200810
14 200815
15 200761
16 20063
17 200255
18 199922
19 199224
20 198491

About Loree Larratt

Loree Larratt is a scholar working on Hematology, Genetics and Transplantation, having authored 80 papers that have together received 3.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (23 papers), Hematopoietic Stem Cell Transplantation (21 papers), Acute Lymphoblastic Leukemia research (21 papers), Chronic Lymphocytic Leukemia Research (18 papers), Blood groups and transfusion (11 papers), Complement system in diseases (10 papers), Lymphoma Diagnosis and Treatment (10 papers) and Renal Diseases and Glomerulopathies (8 papers). The work is most often cited by research in Genetics (1.3k citations), Hematology (1.2k citations) and Pathology and Forensic Medicine (1.0k citations). Loree Larratt has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Andrew R. Belch, Michael J. Mant, Tony Reiman, Brian J. Taylor, Jonathan J. Keats, Christopher A. Maxwell, Linda M. Pilarski, A. Robert Turner, John G. Gribben and Asher Chanan‐Khan. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Bone Marrow Transplantation, Journal of Clinical Oncology and Leukemia Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026